Results 131 to 140 of about 5,556 (167)
Healthcare Resource Utilisation and Costs in Patients with Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Analysis of German Insurance Claims Data. [PDF]
Rheumatol TherDolin P +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Eosinophilic granulomatosis with polyangiitis
Medicina Clínica (English Edition), 2023Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis characterized by the presence of asthma associated with eosinophilia, eosinophilic infiltration of different organs, and vasculitis of small and medium-sized vessels. Although classified as anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, it occurs in less ...
Yann Nguyen, Loïc Guillevin
+7 more sources
Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis
New England Journal of Medicine, 2017Eosinophilic granulomatosis with polyangiitis, first described in the early 1950s by Dr. Jacob Churg and Dr. Lotte Strauss (hence the original name, the Churg–Strauss syndrome), is a rare condition that can affect many organ systems, most commonly the lung, with the majority of patients presenting with asthma symptoms, occasionally complicated by the ...
Djukanović, Ratko, O'Byrne, Paul
openaire +2 more sources
Biologics for eosinophilic granulomatosis with polyangiitis
Current Opinion in Allergy & Clinical Immunology, 2022Purpose of review The link between severe asthma and eosinophilic granulomatosis with polyangiitis (EGPA) in terms of pathophysiological background, clinical manifestations and disease evolution has leaded to investigate the relevance of anti T2 monoclonal antibodies licensed for severe asthma patients as a treatment option for
Caminati, Marco +3 more
openaire +4 more sources
Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies
Current Rheumatology Reports, 2018Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic disseminated vasculitis associated with extravascular granulomas in patients suffering from asthma and tissue eosinophilia. Current therapies to achieve remission and prevent relapse include glucocorticoids and immunosuppressants like cyclophosphamide.With the right treatment, clinical ...
Erika P, Navarro-Mendoza +1 more
openaire +2 more sources
Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)
Seminars in Respiratory and Critical Care Medicine, 2018AbstractEosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg–Strauss syndrome, is a systemic necrotizing vasculitis of small- and medium-size vessels, characterized by asthma and blood eosinophilia. EGPA typically occurs in patients with preexisting asthma, and involves the skin, lungs, and peripheral nerves.
Yann, Nguyen, Loïc, Guillevin
openaire +2 more sources
Eosinophilic Granulomatosis With Polyangiitis
JAMA Dermatology, 2021Abraham M, Korman, Catherine G, Chung
openaire +2 more sources
Eosinophilic fasciitis in eosinophilic granulomatosis with polyangiitis
Rheumatology, 2023Ole Hudowenz +3 more
openaire +2 more sources